A guidance on the assessment and treatment of postmenopausal women at risk from fractures due
1. The operational definition of osteoporosis is based on the T-score for BMD assessed by DXA at the femoral neck or spine and is defined as a value for BMD 2.5 SD or more below the young female adult mean. 2. For clinical purposes, other sites and techniques can be used for diagnosis. 3. Low bone mass (osteopenia) should not be considered a disease category but is intended solely for purpose of epidemiological description. 
Risk Factors for Fragility Fractures

Intervention Thresholds for Pharmacological Intervention
1. The thresholds recommended for decision-making are based on probabilities of major osteoporotic and hip fracture derived from FRAX. These vary in different healthcare systems with variation in "willingness to pay". 2. Women aged over 65 years with a prior fragility fracture can be considered for treatment without the need for further assessment; BMD measurement may be felt more appropriate in younger postmenopausal women. 3. Age-dependent intervention thresholds provide clinically appropriate and equitable access to treatment and have been shown to be cost-effective.
Systems of Care
1. The utility of age-dependent FRAX thresholds in population screening approach has recently been validated as feasible, effective, and health economically viable. 2. Coordinator-based fracture liaison services (FLS) should be used to systematically identify men and women with fragility fracture. Their effectiveness and cost-effectiveness have been established recently.
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